Radium possesses a self-directing capability to accumulate in bones for treatment of bone cancer. The treatment of other cancers requires a method that will shield the Ra from bone absorption and direct it towards specific cancers. This study investigates the probability of tailored Ra/Ba-calixarene systems for such purposes.